We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-3.13%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$532M
AUM Growth
-$39.7M
Cap. Flow
-$48.9M
Cap. Flow %
-9.2%
Top 10 Hldgs %
60.26%
Holding
28
New
1
Increased
10
Reduced
13
Closed
2

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$11.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.93M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.29M
4
ABT icon
Abbott
ABT
+$4.12M
5
ELV icon
Elevance Health
ELV
+$2.4M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$21.1M
2
EXEL icon
Exelixis
EXEL
+$15.7M
3
LLY icon
Eli Lilly
LLY
+$11.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.69M
5
BAX icon
Baxter International
BAX
+$5.84M

Sector Composition

Rank Sector Weight
1 Healthcare 98.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$16.7B
$3.74M 0.7%
252,080
– –
BIIB icon
27
Biogen
BIIB
$29.5B
– –
-71,400
Closed -$21.1M
SPPI
28
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-73,810
Closed -$268K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2016 Portfolio in Review

As of Q4 2016, Sector Gamma AS held 28 positions worth $532M, down 6.9% from $571M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Sector Gamma AS withdrew a net $48.9M in Q4 2016, closing 2 positions and reducing 13 holdings. Its most notable exit was Biogen, an estimated $21.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Alexion Pharmaceuticals worth $5.93M.

  • Sector Gamma AS's largest Q4 2016 buy was Alexion Pharmaceuticals: 48,500 shares worth $5.93M.
  • Sector Gamma AS added most to Shire pic in Q4 2016, an estimated $11.1M increase.
  • Sector Gamma AS's biggest Q4 2016 reduction was Exelixis, cutting an estimated $15.7M.
  • Sector Gamma AS fully exited Biogen in Q4 2016, selling an estimated $21.1M.
  • Sector Gamma AS's ten largest holdings make up 60% of its $532M portfolio in Q4 2016.
  • Sector Gamma AS opened 1 new position and closed 2 in Q4 2016.
  • Sector Gamma AS's portfolio value fell 6.9% quarter-over-quarter to $532M.

Based on Sector Gamma AS's 13F filing for Q4 2016, filed 14 Feb 2017.